HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

California’s SB 1249 Could Plant Seeds For New Plaintiff Cottage Industry

This article was originally published in The Rose Sheet

Executive Summary

The Cruelty-Free Cosmetics Act, passed Aug. 31, conceivably could give rise to consumer suits alleging violation of California’s Unfair Competition Law due to companies’ alleged use of prohibited animal testing to develop cosmetic products or substantiate their safety. Regardless, claiming exemptions under SB 1249 promises to be risky business with limited rewards.

You may also be interested in...



Industry Should Seek Guidance, Supply-Chain Checks For California Cruelty-Free Compliance

Morgan Lewis partner Kathleen Sanzo discusses California’s Cruelty-Free Cosmetics Act, signed into law in late September. Companies should begin establishing compliance programs and supply chain controls and request guidance from California authorities on interpreting the law’s exemptions, she says.

California Cosmetics Bills Are Officially Law; Origins Tries Again With Lipsticks; Cosmetics News In Brief

California continues to lead the charge in state legislation adding to federal cosmetics requirements. Meanwhile Lauder’s Origins brand reenters the lipstick category, and Fusion Brands announces a potentially risky name change.

California’s Cruelty-Free Cosmetics Act Makes New Ingredients Officially Endangered

It’s debatable the extent to which SB 1249, now headed to the governor’s desk, will improve animals’ lot, but cosmetic ingredient innovation is almost certain to suffer. Industry could escalate efforts behind alternative methods development, or there’s another possible solution: federal preemption.

Related Content

Topics

Latest News
UsernamePublicRestriction

Register

RS121814

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel